About ADRX, INC.
ADRx, Inc. is a biotechnology company focused on transforming atomic structures into small molecule therapies for diseases such as Alzheimer's, ALS, and Parkinson's. They are the first company to successfully apply structure-based design to disrupt protein aggregation diseases.
Transforming atomic structures into small molecule therapiesStructure-based design to disrupt protein aggregation diseasesIdentifying, designing, and developing therapeutics to patient-derived pathological protein structuresDiscovering novel small molecule modulators of pathological protein-protein interactions (amyloids and biomolecular condensates)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ADRX, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.